TrialFrontiers in immunology2023

Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study.

Chengxin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.